MMP2 and ovarian cancer: In another study assessing MMP-2, MMP-9 and MT1-MMP in 77 patients with ovarian cancer, strong epithelial MT1-MMP and stromal MMP-9 and FIGO stage were independently associated with shorter survival (33).